Ann L. Oberg

21.8k total citations · 1 hit paper
197 papers, 11.7k citations indexed

About

Ann L. Oberg is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Ann L. Oberg has authored 197 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 63 papers in Oncology and 33 papers in Epidemiology. Recurrent topics in Ann L. Oberg's work include Pancreatic and Hepatic Oncology Research (24 papers), Ovarian cancer diagnosis and treatment (20 papers) and Bone health and osteoporosis research (18 papers). Ann L. Oberg is often cited by papers focused on Pancreatic and Hepatic Oncology Research (24 papers), Ovarian cancer diagnosis and treatment (20 papers) and Bone health and osteoporosis research (18 papers). Ann L. Oberg collaborates with scholars based in United States, Belarus and France. Ann L. Oberg's co-authors include Sundeep Khosla, Sara J. Achenbach, B. Lawrence Riggs, Elizabeth J. Atkinson, L. Joseph Melton, L. Joseph Melton, Gregory A. Poland, Lynn C. Hartmann, Douglas W. Mahoney and L. Joseph Melton and has published in prestigious journals such as Science, JAMA and Circulation.

In The Last Decade

Ann L. Oberg

191 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long‐term Outcome in 2444 Consecutively Treated Patients

2002 546 citations Ann L. Oberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann L. Oberg United States	62	4.4k	2.8k	1.7k	1.7k	1.4k	197	11.7k
Linda L. Demer United States	65	5.0k 1.1×	1.7k 0.6×	1.2k 0.7×	3.5k 2.1×	1.7k 1.2×	162	17.5k
Akira Sasaki Japan	49	3.2k 0.7×	3.4k 1.2×	965 0.6×	2.8k 1.6×	766 0.6×	529	10.5k
Francisco J. Blanco Spain	69	5.3k 1.2×	1.4k 0.5×	2.2k 1.3×	2.7k 1.6×	1.5k 1.1×	612	18.7k
Alexander Stojadinovic United States	64	2.3k 0.5×	3.6k 1.3×	1.7k 1.0×	4.4k 2.6×	1.0k 0.8×	257	12.5k
Matthias W. Beckmann Germany	60	3.6k 0.8×	3.8k 1.4×	2.9k 1.7×	1.4k 0.8×	752 0.5×	654	15.3k
George G. Klee United States	57	2.8k 0.6×	1.7k 0.6×	1.0k 0.6×	2.0k 1.2×	818 0.6×	245	11.6k
Abdul‐Badi Abou‐Samra United States	56	6.0k 1.4×	3.1k 1.1×	709 0.4×	794 0.5×	986 0.7×	257	11.3k
Giuseppe Tonini Italy	62	4.8k 1.1×	8.8k 3.2×	2.3k 1.3×	2.9k 1.7×	934 0.7×	530	17.6k
Chun‐Ying Wu Taiwan	60	2.8k 0.6×	2.0k 0.7×	932 0.5×	4.5k 2.6×	3.2k 2.3×	286	14.9k
Yoshiya Tanaka Japan	80	5.7k 1.3×	5.4k 2.0×	1.0k 0.6×	1.8k 1.1×	2.5k 1.8×	1.1k	30.4k

Countries citing papers authored by Ann L. Oberg

Since Specialization

Citations

This map shows the geographic impact of Ann L. Oberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann L. Oberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann L. Oberg more than expected).

Fields of papers citing papers by Ann L. Oberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann L. Oberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann L. Oberg. The network helps show where Ann L. Oberg may publish in the future.

Co-authorship network of co-authors of Ann L. Oberg

This figure shows the co-authorship network connecting the top 25 collaborators of Ann L. Oberg. A scholar is included among the top collaborators of Ann L. Oberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann L. Oberg. Ann L. Oberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Donahue, Greg, et al.. (2026). Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR). Clinical Cancer Research. 32(4). 756–769.

Bassoy, Esen Yonca, Remya Raja, Fabian Coscia, et al.. (2025). Identification of TTLL8, POTEE, and PKMYT1 as immunogenic cancer-associated antigens and potential immunotherapy targets in ovarian cancer. OncoImmunology. 14(1). 2460276–2460276. 1 indexed citations

Hálfdánarson, Þorvarður R., Erin E. Carlson, Kari G. Rabe, et al.. (2025). Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinoma. Endocrine Related Cancer. 32(4). 1 indexed citations

Li, Qianpeng, Yang Zhang, Sicheng Luo, et al.. (2024). Identify Non-mutational p53 Functional Deficiency in Human Cancers. Genomics Proteomics & Bioinformatics. 22(5).

Asangba, Abigail E., Jun Chen, Krista M. Goergen, et al.. (2023). Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response. Scientific Reports. 13(1). 730–730. 33 indexed citations

Kanakkanthara, Arun, Xiaonan Hou, Valentina Zanfagnin, et al.. (2021). Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma. Cancer Research. 82(2). 307–319. 14 indexed citations

Serebrenik, Artur A., Prokopios P. Argyris, Matthew C. Jarvis, et al.. (2020). The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer. Clinical Cancer Research. 26(13). 3397–3407. 48 indexed citations

Takenaka, Naomi, William R. Bamlet, Ann L. Oberg, et al.. (2020). THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement. Cancer Prevention Research. 14(2). 223–232. 16 indexed citations

Kanakkanthara, Arun, Kiran Kurmi, Xiaonan Hou, et al.. (2019). BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents. Cancer Research. 79(23). 5920–5929. 45 indexed citations

10.

Antwi, Samuel O., William R. Bamlet, Kari G. Chaffee, et al.. (2017). Genetically Predicted Telomere Length is not Associated with Pancreatic Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 26(6). 971–974. 10 indexed citations

11.

Wang, Chen, Sebastian M. Armasu, Kimberly R. Kalli, et al.. (2017). Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes. Clinical Cancer Research. 23(15). 4077–4085. 65 indexed citations

12.

Leonard, Brandon, Gabriel J. Starrett, Matthew J. Maurer, et al.. (2016). APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma. Clinical Cancer Research. 22(18). 4746–4755. 52 indexed citations

13.

Antwi, Samuel O., Kieran Hawthorne, William R. Bamlet, et al.. (2015). Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancer. Cancer Causes & Control. 26(11). 1583–1591. 87 indexed citations

14.

Hendrickson, Andrea E. Wahner, Kieran Hawthorne, Ellen L. Goode, et al.. (2015). Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic. Gynecologic Oncology. 137(1). 77–85. 16 indexed citations

15.

Mehner, Christine, Erin Miller, Aziza Nassar, et al.. (2014). Tumor Cell–Derived MMP3 Orchestrates Rac1b and Tissue Alterations That Promote Pancreatic Adenocarcinoma. Molecular Cancer Research. 12(10). 1430–1439. 52 indexed citations

16.

Fridley, Brooke L., Gregory D. Jenkins, Diane E. Grill, et al.. (2013). Soft truncation thresholding for gene set analysis of RNA-seq data: Application to a vaccine study. Scientific Reports. 3(1). 2898–2898. 15 indexed citations

17.

Reinholz, Monica M., Jeanette E. Eckel‐Passow, S. Keith Anderson, et al.. (2010). Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL®platform. BMC Medical Genomics. 3(1). 60–60. 11 indexed citations

18.

Wang, Liang, Hui Tang, Venugopal Thayanithy, et al.. (2009). Gene Networks and microRNAs Implicated in Aggressive Prostate Cancer. Cancer Research. 69(24). 9490–9497. 125 indexed citations

19.

Hasegawa, Kosei, Takafumi Nakamura, Mary Harvey, et al.. (2006). The Use of a Tropism-Modified Measles Virus in Folate Receptor–Targeted Virotherapy of Ovarian Cancer. Clinical Cancer Research. 12(20). 6170–6178. 73 indexed citations

20.

Dhiman, Neelam, Inna G. Ovsyannikova, Ann L. Oberg, et al.. (2005). Immune Activation at Effector and Gene Expression Levels After Measles Vaccination in Healthy Individuals: A Pilot Study. Human Immunology. 66(11). 1125–1136. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact